Synergetic spin singlet-quintet switching and luminescence in mononuclear Fe(II) 1,3,4-oxadiazole tetradentate chelates with NCBH 3 co-ligand.
Sriram SundaresanJens-Georg BeckerJulian EppelsheimerAlexander E SedykhLuca M CarrellaKlaus Müller-BuschbaumEva RentschlerPublished in: Dalton transactions (Cambridge, England : 2003) (2023)
We report the multi-step synthesis of the tetradentate 2-(naphthalen-2-yl)-5-[ N , N -bis(2-pyridylmethyl)aminomethyl]-1,3,4-oxadiazole ligand (LTetra-ODA) along with its corresponding [Fe II (LTetra-ODA)(NCBH 3 ) 2 ]·1.5CH 3 OH (C1) complex, which is the first mononuclear 1,3,4-oxadiazole based Fe(II) spin crossover (SCO) complex, and its zinc analogue [Zn II (LTetra-ODA)(NCBH 3 ) 2 ]·0.5H 2 O (C2). The spin transition is followed by variable temperature (VT-) X-ray crystallography of [Fe(LTetra-ODA)(NCBH 3 ) 2 ]·1.5CH 3 OH (C1) at 120 and 220 K. The magnetic susceptibility measurements on the bulk sample recorded from 2 to 300 K show that the complex exhibits a complete abrupt reversible spin transition with a T 1/2 of 207 K. The loss of the lattice solvent methanol shifts the T 1/2 slightly to around 210 K. The spin transition in solution for [Fe(LTetra-ODA)(NCBH 3 ) 2 ]·1.5CH 3 OH (C1) was followed using the VT- 1 H-NMR Evans method in CD 3 CN, with a T 1/2 of 357 K. Solid state VT luminescence studies provide some preliminary evidence of interplay of luminescence and spin transition in the [Fe(LTetra-ODA)(NCBH 3 ) 2 ]·1.5CH 3 OH (C1) complex.
Keyphrases
- room temperature
- ionic liquid
- solid state
- density functional theory
- single molecule
- metal organic framework
- quantum dots
- transition metal
- aqueous solution
- high resolution
- magnetic resonance
- computed tomography
- open label
- mass spectrometry
- risk assessment
- magnetic resonance imaging
- molecular dynamics
- lymph node metastasis
- molecularly imprinted
- solar cells